Geoff Mulvihill
The Associated Press
New Jersey, United States
Contact Geoff
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Geoff:
US homeless numbers stay about the same as before pandemic
The Biden administration Monday announced new plans to tackle homelessness, aiming to lower the number of homeless people in the country by 25% by 2025. → Read More
CVS, Walgreens finalize $10B in settlements over opioids
Under the separate deals, states have until the end of the year to agree to drop claims over opioids against Walgreens and CVS to receive the maximum payouts. → Read More
CVS, Walgreens announce opioid settlements totaling $10B
Two of the largest U.S pharmacy chains have agreed in principle to pay a total of about $10 billion to settle lawsuits over the toll of prescription opioids. → Read More
Appeals court reinstates Biden vaccine-or-test mandate for employers
Employees who are not fully vaccinated would have to wear masks and be subject to weekly tests. The case is likely to be decided in the Supreme Court. → Read More
Purdue Pharma opioid settlement rejected by judge over provision protecting Sackler family
U.S. District Court Judge Colleen McMahon found flaws in the way the Purdue Pharma bankruptcy settlement protects members of the Sackler family. → Read More
Biden team defends worker vaccine mandate, wants court cases combined
At least 27 states plus several businesses and associations filed legal challenges in at least six federal appeals court over the COVID-19 vaccine mandate. → Read More
Use of OxyContin profits to fight opioids formally approved
The plan formally approved Friday will turn Purdue Pharma into a new company no longer owned by members of the Sackler family. → Read More
Richard Sackler, ex-head of Purdue Pharma, denies responsibility for opioid crisis
Former Purdue Pharma president and chair Richard Sackler says he, his family and the company do not have any responsibility for the opioid crisis in the U.S. → Read More
Heir: Sacklers won't settle unless freed from opioid suits
The legal protections the Sackler family would get are at the heart of objections to the Purdue Pharma bankruptcy deal from nine states and activists. → Read More
4 companies on verge of settling US opioid lawsuits
The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement in lawsuits across the U.S. → Read More
Fraud overwhelms pandemic-related unemployment programs
Massive fraud in the nation's unemployment system is raising alarms even as leaders in Washington prepare to pour billions of dollars into expanded benefits. → Read More
OxyContin maker Purdue Pharma pleads guilty in criminal case
OxyContin maker Purdue Pharma has pleaded guilty to criminal charges and formally admitted its role in the opioid crisis. → Read More
OxyContin maker to plead guilty to 3 criminal charges
The company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion. → Read More
Worsening opioid crisis overshadowed in presidential race
The drug overdose crisis, which has led to the deaths of more than 470,000 Americans over the last two decades, has been overshadowed during the presidential race. → Read More
After bankruptcy filing, Purdue Pharma may not be off hook
About half of the states and lawyers have agreed to the tentative settlement, but some states intend to object the deal in bankruptcy court and continue lawsuits. → Read More
OxyContin maker reaches tentative opioid-crisis settlement
Purdue Pharma has reached a tentative deal with the about half of the states and thousands of local governments over its role in the nation's deadly opioid crisis. → Read More
A Purdue bankruptcy would make opioids cases even messier
The money from Purdue Pharma local governments have been seeking over the opioid crisis is uncertain as state attorneys general say settlement talks broke down. → Read More
Opioid settlement would divide money based on local impact
The amount being described in proposed settlement pales in comparison to the cost of the nation's opioid epidemic. → Read More
Maker of OxyContin reaches $270M settlement in Oklahoma
The money will go toward establishing the National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa. → Read More
OxyContin maker knew drug would be addictive, court filing reveals
Purdue Pharma is accused of deceiving patients and doctors about the risks of opioids and pushing prescribers to keep patients on the drug longer. → Read More